Key information

Gentian Diagnostics AS serves the global market with sensitive diagnostic tests. Current and pipeline products contribute to improved diagnostics and cost reductions in treatment of kidneys, inflammation, cardiovascular diseases, cancer and viral infections.

On 14th December, 2016, Gentian Diagnostics AS was admitted to the Oslo Stock Exchange list ‘Merkur Market’ under GENT-ME.

Find more information about the Gentian Share on Oslo Børs.
Learn more about Gentian Diagnostics AS here.

Financial Calendar 2019

9TH MAY – ANNUAL REPORT

• 9th May 2019 – Annual Report

9TH MAY – QUARTERLY REPORT Q1

• 9th May 2019 – Quarterly Report – Q1
• 9th May 2019 – Quarterly Presentation – Q1

28TH MAY – ANNUAL GENERAL MEETING

• 28th May 2019 – AGM Minutes GD AS

15TH AUG – HALF–YEARLY REPORT

• 15th Aug 2019 – Quarterly Report – Q2
• 15th Aug – Quarterly Presentation – Q2

7TH NOV – QUARTERLY REPORT – Q3

• 7th Nov 2019 – Quarterly Report – Q3
• 7th Nov 2019 – Quarterly Presentation – Q3
  
  

Extraordinary General Meeting Gentian Diagnostics AS 21/11/2019

The Extraordinary General Meeting for Gentian Diagnostics AS was hold on the 21st of November 2019.

For more information, please see the documents below

• 21st November 2019 – EGM Minutes GD AS
• Notice of Extraordinary General Meeting for Gentian Diagnostics AS 21.11.2019
• 2019 Proposal from Nomination Committee
  
  

28^th of May 2019: Annual General Meeting

Annual General Meeting for Gentian Diagnostics AS was hold on the 28th of May 2019. For more information, please see the notice and documents below:

• 28th May 2019 – AGM Minutes GD AS
• Notice of Annual General Meeting for Gentian Diagnostics AS 28.05.2019
• 2018 Annual Report Gentian Diagnostics AS
• 2019 Proposal from Nomination Committee
  
  

Presentations

• 9th May 2019 – Quarterly Presentation – Q1
• 15h Aug 2019 – Quarterly Presentation – Q2
• 7th Nov 2019 – Quarterly Presentation – Q3

Historicals